MRCP+

Perspectum

MRCP+ allows existing MRCP data to be enhanced and quantitatively characterized using image processing techniques. The technology can enhance the data from conventional MRCP without needing to inject contrast agent, enabling 3D visualization of ducts.
MRCP+ calculates quantitative 3D biliary system models that enable measurement of bile duct widths and automatic detection of regions of variation of duct widths. MRCP+ includes tools for interactive segmentation and labelling of the biliary system and structures. It allows for regional volumetric analysis of the biliary tree, pancreatic duct, and gallbladder.

Information source: Public
Last updated: May 2, 2024

General Information

General
Product name	MRCP+
Company	Perspectum
Subspeciality	Abdomen
Modality	MR
Disease targeted	Primary sclerosing cholangitis (PSC), Primary biliary cholangitis (PBC), and Biliary Atresia, liver transplantation
Key-features	Biliary system segmentation, width and volume quantification
Suggested use

Technical Specifications

Data characteristics
Population
Input	Magnetic resonance cholangiopancreatography (MRCP)
Input format
Output
Output format
Technology
Integration
Deployment
Trigger for analysis
Processing time

Regulatory

Certification
CE	Certified, Class unknown
FDA	510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)

Market

Market presence
On market since	01-2019
Distribution channels	Nuance PIN, Calantic, Eureka Clinical AI
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on

Evidence

Evidence
Peer reviewed papers on performance	Quantitative MRCP and metrics of bile duct disease over time in patients with primary sclerosing cholangitis: A prospective study (read)
Non-peer reviewed papers on performance
Other relevant papers